tiprankstipranks
Novavax (DE:NVV1)
XETRA:NVV1
Holding DE:NVV1?
Track your performance easily

Novavax (NVV1) Financial Statements

7 Followers

Novavax Financial Overview

Novavax's market cap is currently ―. The company's EPS TTM is €-2.26; its P/E ratio is -3.83; Novavax is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is €-0.57. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 93.86M$ 291.34M$ 186.99M$ 424.43M$ 80.95M
Gross Profit$ 34.65M$ -52.43M$ 186.99M$ 424.43M$ 46.87M
EBIT$ -141.18M-$ -126.42M$ 63.18M$ -291.61M
EBITDA$ -129.03M-$ -115.10M$ 73.25M$ -282.57M
Net Income Common Stockholders$ -147.55M$ -178.39M$ -130.78M$ 58.01M$ -293.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 480.59M$ 568.50M$ 651.10M$ 516.27M$ 635.28M
Total Assets$ 1.35B$ 1.80B$ 1.66B$ 1.69B$ 1.54B
Total Debt$ 229.33M$ 229.08M$ 222.11M$ 198.94M$ 199.06M
Net Debt$ -251.25M$ -339.42M$ -428.99M$ -317.33M$ -436.23M
Total Liabilities$ 2.22B$ 2.51B$ 2.34B$ 2.44B$ 2.44B
Stockholders Equity$ -867.08M$ -716.93M$ -678.35M$ -754.52M$ -895.58M
Cash Flow-
Free Cash Flow$ -90.48M-$ -57.86M$ -178.89M$ -345.39M
Operating Cash Flow$ -83.60M$ -176.80M$ -39.70M$ -171.92M$ -325.59M
Investing Cash Flow$ -7.25M$ -9.08M$ -18.39M$ -7.78M$ -23.56M
Financing Cash Flow$ 5.89M$ 100.39M$ 197.12M$ 61.34M$ -354.38M
Currency in USD

Novavax Earnings and Revenue History

Novavax Debt to Assets

Novavax Cash Flow

Novavax Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis